Zenosense, Inc.: New Patent Application for Additional MIDS Detection Method

Press release Jan 23, 2017 OTC Disclosure & News Service Zenosense, Inc.: New Patent Application for Additional MIDS Detection Method VALENCIA, SPAIN–(Marketwired – Jan 23, 2017) – Zenosense, Inc. (OTCQB: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care (“POC”) handheld device…